Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Crossref DOI link: https://doi.org/10.1007/s40273-015-0351-2
Published Online: 2015-12-21
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pandor, Abdullah
Pollard, Daniel
Chico, Tim
Henderson, Robert
Stevenson, Matt
Funding for this research was provided by:
National Institute for Health Research (GB) (11/119/01)
Text and Data Mining valid from 2015-12-21